| Name | Cvs Pharmacy #05675 |
|---|---|
| Organization Name | New Jersey Cvs Pharmacy Llc |
| Location | 955 West Bay Ave, Barnegat, New Jersey 08005 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (609) 660-7699 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Millennium: The Takeda Oncology Company today announced that two studies presented at the 51st American Society of Hematology (ASH) Annual Meeting found that VELCADE based regimens are more cost-effective for payers and reduced out-of-pocket costs for patients than other commonly used multiple myeloma treatments.
Today's headlines include reports that a federal judge in Wisconsin heard arguments in a health law challenge brought by a U.S. senator.
A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in the leg, offering an alternative to surgical revascularization. Peripheral artery disease affects about 12 to 14 percent of the general population, and revascularization can be achieved through bypass surgery or a number of minimally invasive endovascular techniques that seek to reduce or eliminate symptoms of reduced blood flow by improving tissue perfusion.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 2 days ago
| NPI Number | 1316253503 |
| Organization Name | NEW JERSEY CVS PHARMACY, L.L.C. |
| Doing Business As | CVS PHARMACY # 05675 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 955 West Bay Ave, Barnegat, NJ 08005 |
| Phone Number | 609-660-7699 |
News Archive
Millennium: The Takeda Oncology Company today announced that two studies presented at the 51st American Society of Hematology (ASH) Annual Meeting found that VELCADE based regimens are more cost-effective for payers and reduced out-of-pocket costs for patients than other commonly used multiple myeloma treatments.
Today's headlines include reports that a federal judge in Wisconsin heard arguments in a health law challenge brought by a U.S. senator.
A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in the leg, offering an alternative to surgical revascularization. Peripheral artery disease affects about 12 to 14 percent of the general population, and revascularization can be achieved through bypass surgery or a number of minimally invasive endovascular techniques that seek to reduce or eliminate symptoms of reduced blood flow by improving tissue perfusion.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 2 days ago
News Archive
Millennium: The Takeda Oncology Company today announced that two studies presented at the 51st American Society of Hematology (ASH) Annual Meeting found that VELCADE based regimens are more cost-effective for payers and reduced out-of-pocket costs for patients than other commonly used multiple myeloma treatments.
Today's headlines include reports that a federal judge in Wisconsin heard arguments in a health law challenge brought by a U.S. senator.
A new balloon catheter system could advance the endovascular approach to treating obstructed arteries in the leg, offering an alternative to surgical revascularization. Peripheral artery disease affects about 12 to 14 percent of the general population, and revascularization can be achieved through bypass surgery or a number of minimally invasive endovascular techniques that seek to reduce or eliminate symptoms of reduced blood flow by improving tissue perfusion.
Mallinckrodt today announced that the U.S. Food and Drug Administration has approved the New Drug Application for PENNSAID (diclofenac sodium topical solution) 2% w/w. PENNSAID 2% is a topical non-steroidal anti-inflammatory drug approved for use in the treatment of the pain of osteoarthritis of the knee(s).
› Verified 2 days ago
Rite Aid Pharmacy 02529 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 895 W Bay Ave, Barnegat, New Jersey 08005 Phone: (609) 698-2329 | |
Cvs Pharmacy #05675 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 955 West Bay Ave, Barnegat, New Jersey 08005 Phone: (609) 660-7699 | |
Walgreens #9503 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 879 W Bay Ave, Barnegat, New Jersey 08005 Phone: (609) 698-7035 | |
Jersey Shore Pharmacy Type: Pharmacy Location: 580 N Main St, Barnegat, New Jersey 08005 Phone: (609) 660-1111 |